All Pharma News
Affini-T: First Patient Dosed In KRAS G12V Trial, ASCO 2024 Presentation

Affini-T: First Patient Dosed In KRAS G12V Trial, ASCO 2024 Presentation
BUSINESSWIRE
28 May 2024
Share Share
Affini-T: KRAS, TP53 Preclinical Data At ASGCT Annual Meeting

Affini-T: KRAS, TP53 Preclinical Data At ASGCT Annual Meeting
BUSINESSWIRE
01 May 2024
Share Share
Affini-T Presents Preclinical Data at the AACR Annual Meeting 2024

Affini-T Presents Preclinical Data at the AACR Annual Meeting 2024
BUSINESSWIRE
07 Apr 2024
Share Share
Affini-T to Present Preclinical Data from its Programs Targeting KRAS G12D

Affini-T to Present Preclinical Data from its Programs Targeting KRAS G12D
BUSINESSWIRE
13 Mar 2024
Share Share
Affini-T to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Affini-T to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BUSINESSWIRE
07 Jan 2024
Share Share
Affini-T Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson as CFO

Affini-T Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson as CFO
BUSINESSWIRE
13 Nov 2023
Share Share
Affini-T Therapeutics to Present Preclinical Gene Editing Data from KRAS G12D

Affini-T Therapeutics to Present Preclinical Gene Editing Data from KRAS G12D
BUSINESSWIRE
31 Oct 2023
Share Share
Affini-T plans to go public in 2024

Affini-T plans to go public in 2024
Max Bayer FIERCE BIOTECH
25 Jul 2023
Share Share
Affini-T to close Seattle lab as it concentrates in Boston

Affini-T to close Seattle lab as it concentrates in Boston
Kyle LaHucik ENDPTS
20 Jul 2023
Share Share
Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO

Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO
Alex Hoffman ENDPTS
02 Jun 2023
Share Share